Dexamethasone
Indications
Registered South African indications:
- Inflammatory conditions of the eye
- Inflammatory conditions of the external auditory meatus
Cautions
Contraindication
- Hypersensitivity to the active ingredient or any of its excipients
- Infections
Caution
- Pregnancy
- Breastfeeding
- Concomitant use of soft contact lenses
- Diseases causing thinning of cornea/sclera
- Glaucoma
Adult dosage
Forms avail. in SA and covered in this monograph: opd, dro
Non-infective inflammatory conditions of the eye
- Ophthalmic (opd): Initial: 1-2 drops into affected eye(s), 1hrly until adequate response; Maintenance: 1-2 drops into affected eye(s), 6-8hrly
Nasolacrimal occlusion or gently closing the eyelid after admin. is recommended
Should not be used for longer than one week except under ophthalmic supervision
Steroid responsive inflammatory conditions of the external auditory meatus
- Allergic otitis
- Purulent and non-purulent infective otitis externa
- Otic (dro): 3-4 drops into affected ear(s), 6-12hrly
Paediatric dosage
Not established for use in children below 2 years
Special populations
Pregnancy
- Caution
- Insufficient data are available on the use of dexamethasone eye drops/solution in human pregnancy to assess possible harmful effects. Corticosteroids cross the placenta. Teratogenic effects have been observed in animals. However, there is no evidence to date that teratogenic effects are induced in humans. After systemic use of corticosteroids, at higher doses, effects on the unborn/neonate (intrauterine growth inhibition, inhibition of the function of the adrenal cortex) have been reported. However, these effects have not been reported for ocular use
- Insufficient data are available on the use of dexamethasone eye drops/solution in human pregnancy to assess possible harmful effects. As a precautionary measure, it is preferable to avoid the use of dexamethasone eye drops/solution during pregnancy
Breastfeeding
- Caution; not recommended
- It is not known whether this medicine is excreted in breast milk. However, the total dose of dexamethasone is low. Dexamethasone eye drops/solution can be used during breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Central Nervous System Disorders
- Disgeusia
- Dizziness
- Headache
Cardiovascular System Disorders
- Hypertension
- Aneurysm
Respiratory System Disorders
- Bronchitis
Immune Blood and Lymphatic System Disorders
- Hypersensitivity
Sensory Disorders
- Keratitis
- Conjunctivitis
- Keratoconjunctivitis sicca
- Corneal staining
- Photophobia
- Blurred vision
- Eye pruritus
- Foreign body sensation in eyes
- Lacrimation increased
- Eyelid margin crusting
- Ocular hyperaemia
- Increased intraocular pressure
- Reduced visual acuity
- Corneal erosion
- Eyelid ptosis
- Eye pain
- Mydriasis
Interactions
- CYP3A inhibitors
- Topical non-steroidal anti-inflammatory drugs
- Phenytoin
- Phenobarbitone
- Ephedrine
- Rifampicin
- Anticholinergics
Monitoring
Intraocular pressure
Prescribing points
Dexamethasone eye drops - EML (Hospital)
Dexamethasone ear drops - Non-EML
- In patients who have received more than physiological doses of systemic corticosteroids (approximately 1 mg dexamethasone) for greater than 3 weeks, withdrawal should not be abrupt
Mechanism of action
Suppresses inflammation by inhibiting oedema, fibrin deposition, capillary leakage, and phagocytic migration during the inflammatory response. Glucocorticoids inhibit vascular endothelial growth factor, a potent promoter of vascular permeability.
Dosage forms
- Eye drops
- Ophthalmic gel drop
Formulation
Eye/Ear drops (per 100ml) 0.1g
- Maxidex (Alcon) originator
Eye drops (per 100ml) 0.1g
- Spersadex 0.1% (Adcock) originator
Also available in the following forms: Injection and implant.
COMBINATION PREPARATIONS
Chloramphenicol/ Dexamethasone
Eye drops (per ml) 5mg/1mg
- Spersadex Comp (Adcock) originator
Chloramphenicol/ Dexamethasone/ Neomycin
Eye drops (per ml) 2mg/0.5mg/5mg
- Covomycin D (Adcock) originator
Polymyxin B/ Dexamethasone/ Neomycin
Eye drops (per ml) 6000iu/1mg/3500iu
- Maxitrol (Alcon) originator
Eye ointment (per ml) 6000iu/1mg/3500iu
- Maxitrol Ointment (Alcon) originator
Dexamethasone/ Framycetin
Eye/Ear drops (per ml) 0.5mg/5mg
- Sofradex Ear/Eye (Sanofi)
Dexamethasone/ Tobramycin
Eye ointment (per ml) 1mg/0.3%
- Tobradex Eye Ointment (Alcon) originator
Eye drops (per ml) 1mg/0.3%
- Tobradex Eye Drops (Alcon) originator
References
1. SmPC: Dexamethasone 1mg/ml Eye Drops, Thea Pharmaceuticals Ltd; Last updated on eMC: 30 Aug 2018; Downloaded online 05 Sep 2018 [https://www.medicines.org.uk/emc/product/5343/smpc] 2. SmPC: Dexamethasone 0.1%w/v Eye Drops, Thea Pharmaceuticals Ltd; Last updated on eMC: 14 Jul 2017; Downloaded online 05 Sep 2018 [https://www.medicines.org.uk/emc/product/840/smpc] 3. SAMF_12th Edition_Page 574 4.PI: Spersadex 01% Eye drops: Adcock Ingram Limited: Date of registration: 22 Nov 2006 [https://drive.google.com/drive/folders/1uIP8iC684qdDmt4yoMxZgpY8o-McWJSL] 6. U2D: Dexamethasone (ophthalmic): Drug information, UpToDate; Downloaded online 04 Sep 2018 [https://www.uptodate.com/contents/dexamethasone-ophthalmic-drug-information] 7. NAPOS The Drug Database for Acute Porphyria: S03BA01 Dexamethasone; Accessed online 04 Sep 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=S03BA01&l=gbr] 8. South African Institute for Drug-Free Sport: Maxidex Suspension; Accessed online 04 Sep 2018 [http://www.drugfreesport.org.za/online-medication-check/] 9.SmPC: Maxidex, Novartis Pharmaceuticals UK Ltd: Last updated 10 Dec 2019; updated 8 April 2020, [https://www.medicines.org.uk/emc/product/840/smpc] 10. Dr Irhuma. Updates for dexamethasone. Dated 13 November 2019. Updated 8 April 2020.
Brands & products
3 products · cached snapshot- Spersadex
- Maxidex
OPGOphthalmic gel drop· 1 product
from R184.60| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Dexagel | 0.985 mg/g | 5 | Soflens (Pty) Ltd | R184.60 |
OPDEye drops· 2 products
from R216.38| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Spersadex 0.1% | 0.1 g/100ml | 5 | Adcock Ingram Limited | R216.38 |
| Maxidex | 1 mg/ml | 5 | Novartis South Africa (Pty) Ltd | R236.41 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
Interacts with 54 known drugs
Check against other drugs →- Amphotericin B
- Aprepitant
- Aspirin
- Axitinib
- Carbamazepine
- Caspofungin
- Ciclosporin
- Clarithromycin
- Conjugated Oestrogens
- Cyclophosphamide
- Dabrafenib
- Darunavir
- Dasatinib
- Docetaxel
- Efavirenz
- Enzalutamide
- Ephedrine Sulphate
- Erythromycin
- Etravirine
- Fosaprepitant
- Furosemide
- Hydrocortisone
- Imatinib
- Indinavir
- Indomethacin
- Isoniazid
- Itraconazole
- Ixabepilone
- Ketoconazole
- Lapatinib
- Lenacapavir
- Methotrexate
- Midazolam
- Mifepristone
- Neratinib
- Phenobarbitone
- Phenytoin
- Pomalidomide
- Posaconazole
- Praziquantel
- + 14 more
Cited in 60+ documents
- GuidelinesCroup12×
- GuidelinesClinical Management of Suspected or Confirmed COVID-19 Disease, Version 59×
- GuidelinesAcute Meningitis8×
- GuidelinesReferences - Oncology Emergencies7×
- GuidelinesReferences: Arthroplasty6×
- GuidelinesLocally and Regionally Administered Analgesic Drugs5×
- GuidelinesAcid-Base Disorders4×
- GuidelinesNausea and Vomiting4×
- GuidelinesNonopioid Analgesics and Co-Analgesics4×
- GuidelinesCOVID-19 Protocol Version 10 - Charlotte Maxeke Johannesburg Academic Hospital / Gauteng ICU Group3×
- GuidelinesCushing Syndrome3×
- GuidelinesIntraoperative Recommendations and Anaesthetic Techniques3×
- GuidelinesReferences - Infective/Infectious Disease3×
- GuidelinesSpinal Cord Compression3×
- GuidelinesAnaesthesia Equipment and Anaesthetising Facilities: Medication2×
- GuidelinesCIRCULAR H 111 of 2020 - The RECOVERY Study: Interim Guidance on the Use of Steroids in COVID-19 patients2×
- GuidelinesComa2×
- GuidelinesEmerging Respiratory Pathogens2×
- GuidelinesHirsutism2×
- GuidelinesICU Medications2×
- GuidelinesInfection and drug dosages2×
- GuidelinesMedicines to Treat Complications of Anaesthesia2×
- GuidelinesPain Management2×
- GuidelinesPeritonsillar Abscess (Quinsy)2×
- GuidelinesReferences - Acute Pain2×
- GuidelinesReferences - Endocrine System2×
- GuidelinesReferences - Medicines used in Palliative Care2×
- GuidelinesReferences - Obstetrics2×
- GuidelinesSpinal Cord Compression - Paediatric Palliative Care2×
- GuidelinesSuperior Vena Cava Obstruction2×
- GuidelinesAcute Bacterial Tracheitis
- GuidelinesAcute Viral Laryngotracheobronchitis (Croup)
- GuidelinesAnalgesia during Pregnancy, Childbirth, the Puerperium and Lactation
- GuidelinesAnalgesic Medication for Children with Cancer Pain
- GuidelinesAnorexia, Asthenia and Cachexia
- GuidelinesAnti-Cancer Treatments
- GuidelinesArthritis, Septic (Pyogenic)
- GuidelinesCavernous Sinus Thrombophlebitis
- GuidelinesCommon prescribed drug dosage for children
- GuidelinesConditions Causing Amenorrhoea
- GuidelinesCoronavirus Disease-19 (Covid-19) in Pregnancy
- GuidelinesCritical Care Management of Patient Confirmed with COVID-19
- GuidelinesDelirium
- GuidelinesDepression
- GuidelinesDysphagia
- GuidelinesEpiglottitis
- GuidelinesGeneral Principles
- ArticlesHydrocortisone for the prevention of postoperative delirium in digestive surgery (HyPOD)
- GuidelinesHyperemesis Gravidarum
- GuidelinesInfectious and Parasitic Conditions
- GuidelinesIntestinal Obstruction
- GuidelinesLaryngotracheobronchitis, Acute Viral (Croup)
- GuidelinesLocal and Regional Anaesthesia
- GuidelinesMeningitis, Acute Bacterial
- GuidelinesMeningococcal Septicaemia
- GuidelinesMyasthenic Crisis (MC)
- GuidelinesNeurocysticercosis
- GuidelinesNeurocysticercosis
- GuidelinesNon-Penetrating Eye Injury
- GuidelinesOedema, Cerebral